[1]霍伟,曲范杰,范丽听. 吉西他滨联合卡铂线治疗晚期非小细胞肺癌疗效观察[J]. 临床肿瘤学杂志, 2006, 11(11): 828-829.Huo Wei,Qu Fanfie,Fan Lixin. Efects of gemcitabine plus carboplatin in threatment of chem onaive patients with advanced non-small cell lung cancer[J]. Chinese Clinical Oncology, 2006, 11(11):828-829(in Chinese).
[2]Paul A, Bunn J. Triplet chemotherapy with gemcitabine, a platinum and a third agent in the treatment of advanced non-small-cell lung cancer[J]. Semin Oncol, 1999, 26(1): 25-30.
[3]Hertel LW, Kroin JS. Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosides [J]. J Org Chem, 1988, 53 (11) : 2406-2409.
[4]Chou TaSen, Heath PC. Process for and intermediates of 2’-2’-difluoronucleosides:USA patent,US5223608[P]. 1990-07-12.
[5]顾海成,马玉恒,王伟. 盐酸吉西他滨的合成方法:中国,102417533A[P]. 2011-10-28.
[6]李高. 稳定同位素标记药物在临床药代动力学研究中的应用[J]. 中国临床药理学杂志, 2000, 1(16): 58-62.LI Gao. The Application of Stable Isotope Labelled Drugs in Clinical Pharmacokinetic Study[J]. The Chinese Journal of Clinical Pharmacology, 2000, 1(16): 58-62(in Chinese).
[7] Victor C. Nelson. Synthesis of isotopically labelled DNA degradation products for use in mass spectrometric studies of cellular DNA damage[J]. Journal of Labelled Compounds and Radiopharmaceuticals, 1996, 38(8): 713–723 ;
[8] 蔡东,商琳琳,贾云宏,等. 胞嘧啶的合成研究进展[J]. 化工中间体, 2009, 2: 14-17; Cai Dong, Shang Linlin, Jia Yunhong, etc. Progress in the synthesis of cytosine[J]. Chemical Intermediates, 2009, 2: 14-17(in Chinese);
[9] 霍利春,李春新,刘茵. 胞嘧啶合成新工艺[J]. 甘肃石油和化工, 2012, 2:28-32. Huo Lichun, Li Chunxin, Liu Yin. New technology of synthesis Cytosine[J]. gansu shiyou he huagong, 2012, 2:28-32(in Chinese). |